How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Safety | |||
| Duration | |||
| Onset | 15–30 minutes | — | |
| Total | 6–10 hours | — | |
| Pharmacology | |||
| Receptor activity | — | Sigma non-opioid intracellular receptor 1Kappa-type opioid receptorDelta-type opioid receptor | |
TripSit summary
A sigma-1 receptor agonist derived structurally from PCP. It has cognitive enhancing effects as well as antidepressant effects, and shows promise in treating many nervous system diseases such as ALS and parkinsons.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.